ursodeoxycholic acid has been researched along with Hematologic Malignancies in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hägglund, H; Juvonen, E; Mattsson, J; Nihtinen, A; Remberger, M; Remes, K; Ringdén, O; Ruutu, T; Volin, L | 1 |
| Aotsuka, N; Maruta, A; Matsuzaki, M; Nishimura, M; Oh, H; Ohashi, K; Okamoto, S; Saito, K; Sakamaki, H; Takahashi, S; Tanabe, J; Tanaka, T; Watanabe, R; Yonekura, S | 1 |
2 trial(s) available for ursodeoxycholic acid and Hematologic Malignancies
| Article | Year |
|---|---|
Improved survival with ursodeoxycholic acid prophylaxis in allogeneic stem cell transplantation: long-term follow-up of a randomized study.
Topics: Adult; Bilirubin; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Myeloablative Agonists; Prospective Studies; Recurrence; Survival Analysis; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Ursodeoxycholic Acid | 2014 |
The Japanese multicenter open randomized trial of ursodeoxycholic acid prophylaxis for hepatic veno-occlusive disease after stem cell transplantation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cholagogues and Choleretics; Combined Modality Therapy; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Hepatic Veno-Occlusive Disease; Humans; Male; Treatment Outcome; Ursodeoxycholic Acid | 2000 |